Cargando…
A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645453/ http://dx.doi.org/10.1186/2051-1426-3-S2-P165 |
| _version_ | 1782400816652484608 |
|---|---|
| author | Papadopoulos, Kyriakos P Tsai, Frank Hamid, Omid Xiao, Feng Steele, Keith E Rebelatto, Marlon C Robbins, Paul B Karakunnel, Joyson J Lai, Dominic W Mahipal, Amit |
| author_facet | Papadopoulos, Kyriakos P Tsai, Frank Hamid, Omid Xiao, Feng Steele, Keith E Rebelatto, Marlon C Robbins, Paul B Karakunnel, Joyson J Lai, Dominic W Mahipal, Amit |
| author_sort | Papadopoulos, Kyriakos P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645453 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46454532015-11-20 A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors Papadopoulos, Kyriakos P Tsai, Frank Hamid, Omid Xiao, Feng Steele, Keith E Rebelatto, Marlon C Robbins, Paul B Karakunnel, Joyson J Lai, Dominic W Mahipal, Amit J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645453/ http://dx.doi.org/10.1186/2051-1426-3-S2-P165 Text en Copyright © 2015 Papadopoulos et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Papadopoulos, Kyriakos P Tsai, Frank Hamid, Omid Xiao, Feng Steele, Keith E Rebelatto, Marlon C Robbins, Paul B Karakunnel, Joyson J Lai, Dominic W Mahipal, Amit A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors |
| title | A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors |
| title_full | A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors |
| title_fullStr | A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors |
| title_full_unstemmed | A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors |
| title_short | A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors |
| title_sort | phase i study to evaluate the safety and antitumor activity of durvalumab (medi4736) in combination with tremelimumab in patients with advanced solid tumors |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645453/ http://dx.doi.org/10.1186/2051-1426-3-S2-P165 |
| work_keys_str_mv | AT papadopouloskyriakosp aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT tsaifrank aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT hamidomid aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT xiaofeng aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT steelekeithe aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT rebelattomarlonc aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT robbinspaulb aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT karakunneljoysonj aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT laidominicw aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT mahipalamit aphaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT papadopouloskyriakosp phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT tsaifrank phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT hamidomid phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT xiaofeng phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT steelekeithe phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT rebelattomarlonc phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT robbinspaulb phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT karakunneljoysonj phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT laidominicw phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors AT mahipalamit phaseistudytoevaluatethesafetyandantitumoractivityofdurvalumabmedi4736incombinationwithtremelimumabinpatientswithadvancedsolidtumors |